Cardicor 10mg tablets

País: Reino Unido

Idioma: inglés

Fuente: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingredientes activos:

Bisoprolol fumarate

Disponible desde:

Merck Serono Ltd

Código ATC:

C07AB07

Designación común internacional (DCI):

Bisoprolol fumarate

Dosis:

10mg

formulario farmacéutico:

Oral tablet

Vía de administración:

Oral

clase:

No Controlled Drug Status

tipo de receta:

Valid as a prescribable product

Resumen del producto:

BNF: 02040000; GTIN: 5013837319004

Información para el usuario

PAGE 1
1235481-E / TW1320108
Package leaflet: Information for the user
CARDICOR
® 1.25 MG FILM-COATED TABLETS
CARDICOR
® 2.5 MG FILM-COATED TABLETS
CARDICOR
® 3.75 MG FILM-COATED TABLETS
CARDICOR
® 5 MG FILM-COATED TABLETS
CARDICOR
® 7.5 MG FILM-COATED TABLETS
CARDICOR
® 10 MG FILM-COATED TABLETS
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU
START TAKING THIS MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor
or your pharmacist.
• This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them,
even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side effects
not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1. What Cardicor is and what it is used for
2. What you need to know before you take Cardicor
3. How to take Cardicor
4. Possible side effects
5. How to store Cardicor
6. Contents of the pack and other information
1. WHAT CARDICOR IS AND WHAT IT IS USED FOR
The active substance in Cardicor is bisoprolol.
Bisoprolol belongs to a group of medicines called
beta-blockers. These medicines work by affecting the
body`s response to some nerve impulses, especially
in the heart. As a result, bisoprolol slows down the
heart rate and makes the heart more efficient at
pumping blood around the body.
Heart failure occurs when the heart muscle is weak
and unable to pump enough blood to supply the
body’s needs. Cardicor is used to treat stable chronic
heart failure.
It is used in combination with other medicines
suitable for this condition (such as ACE-inhibitors,
diuretics, and heart glycosides).
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE
CARDICOR
DO NOT TAKE CARDICOR
Do not take Cardicor if one of the following
conditions applies to you:
Bisoprolol fumarate
• allergy (hypersensitivity) to bisoprolol or to any
of the other ingredients (see section 6 ‘What

Ficha técnica

OBJECT 1
CARDICOR 1.25MG FILM COATED TABLETS
Summary of Product Characteristics Updated 15-Sep-2015 | Merck
1. Name of the medicinal product
Cardicor 1.25 mg film-coated tablets
Cardicor 2.5 mg film-coated tablets
Cardicor 3.75 mg film-coated tablets
Cardicor 5 mg film-coated tablets
Cardicor 7.5 mg film-coated tablets
Cardicor 10 mg film-coated tablets
2. Qualitative and quantitative composition
Cardicor 1.25 mg:
Each tablet contains 1.25 mg bisoprolol fumarate
Cardicor 2.5 mg:
Each tablet contains 2.5 mg bisoprolol fumarate
Cardicor 3.75 mg:
Each tablet contains 3.75 mg bisoprolol fumarate
Cardicor 5 mg:
Each tablet contains 5 mg bisoprolol fumarate
Cardicor 7.5 mg:
Each tablet contains 7.5 mg bisoprolol fumarate
Cardicor 10 mg:
Each tablet contains 10 mg bisoprolol fumarate
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Film-coated tablet.
Cardicor 1.25 mg
white, round film-coated tablets
Cardicor 2.5 mg
white, heart-shaped, scored and film-coated tablets
Cardicor 3.75 mg
off-white, heart-shaped, scored and film-coated tablets
Cardicor 5 mg
yellowish white, heart-shaped, scored and film-coated tablets
Cardicor 7.5 mg
pale yellow, heart-shaped, scored and film-coated tablets
Cardicor 10 mg
pale orange - light orange, heart-shaped, scored and film-coated
tablets
The scored tablets can be divided into two equal doses.
4. Clinical particulars
4.1 Therapeutic indications
Treatment of stable chronic heart failure with reduced systolic left
ventricular function in addition to ACE
inhibitors, and diuretics, and optionally cardiac glycosides (for
additional information see section 5.1).
4.2 Posology and method of administration
Standard treatment of CHF consists of an ACE inhibitor (or an
angiotensin receptor blocker in case of
intolerance to ACE inhibitors), a beta-blocker, diuretics, and when
appropriate cardiac glycosides.
Patients should be stable (without acute failure) when bisoprolol
treatment is initiated.
It is recommended that the treating physician should be experienced in
the manag